Lin Hang, Cheng Yuanda, Zhang Chunfang
Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha 410008, China.
Zhongguo Fei Ai Za Zhi. 2019 Jul 20;22(7):470-476. doi: 10.3779/j.issn.1009-3419.2019.07.10.
Epithelioid hemangioendothelioma (EHE) is a rare vascular neoplasm that develops from vascular endothelial cells. It has been reported to occur many sites of body, but the most common EHE presentations are soft tissue (limbs), bone, liver and lung. Compared with other pulmonary tumors, pulmonary epithelioid hemangioendothelioma (P-EHE) is relatively rare. According to a literature review, more than 100 cases have been described all over the world. Due to the low incidence of P-EHE, lack of specificity in clinical symptoms and radiological findings, it is often misdiagnosed. Meanwhile, many patients do not receive appropriate treatment, resulting in poor prognosis in some cases. Histology and immunohistochemical methods are essential for diagnosis. However, there is no established standard treatment for P-EHE, because of the rarity of the disease. When the lesions are small and limited in number, surgical is the best treatment, achieving the purpose of diagnosis and treatment at the same time. This article tries to present the etiopathogenesis, clinical manifestations, diagnosis, treatment and prognosis of P-EHE. .
上皮样血管内皮瘤(EHE)是一种罕见的起源于血管内皮细胞的血管肿瘤。据报道,它可发生于身体的多个部位,但最常见的EHE表现部位是软组织(四肢)、骨骼、肝脏和肺部。与其他肺部肿瘤相比,肺上皮样血管内皮瘤(P-EHE)相对少见。根据文献综述,全世界已报道了100多例病例。由于P-EHE发病率低,临床症状和影像学表现缺乏特异性,它常被误诊。同时,许多患者未得到恰当治疗,在某些情况下导致预后不良。组织学和免疫组化方法对诊断至关重要。然而,由于该疾病罕见,目前尚无针对P-EHE的确立的标准治疗方法。当病变较小且数量有限时,手术是最佳治疗方法,可同时达到诊断和治疗的目的。本文试图阐述P-EHE的病因、临床表现、诊断、治疗及预后。